Lyme Disease Diagnosed by Alternative Methods: A Phenotype Similar to That of Chronic Fatigue Syndrome.
暂无分享,去创建一个
J. Singer | J. Gardy | T. Steiner | P. Tang | M. Morshed | D. Patrick | Ruth R. Miller | K. Shojania | Shoshana M. Parker
[1] J. Kilstein,et al. New diagnostic criteria for fibromyalgia: Here to stay? , 2015, Reumatologia clinica.
[2] S. Moyano,et al. New Diagnostic Criteria for Fibromyalgia: Here to Stay? , 2015 .
[3] M. Gee,et al. Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. , 2015, Health promotion and chronic disease prevention in Canada : research, policy and practice.
[4] M. Pavlicova,et al. A comparison of lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] R. Dattwyler,et al. Comparison of lyme disease serologic assays and lyme specialty laboratories. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] P. Tang,et al. 1725Surveillance for Borrelia burgdorferi in Ixodes Ticks and Mice in British Columbia , 2014, Open Forum Infectious Diseases.
[7] Umed Ajani,et al. Summary of notifiable diseases--United States, 2012. , 2014, MMWR. Morbidity and mortality weekly report.
[8] J. Gardy,et al. A metagenomic approach to investigate the microbial causes of myalgic encephalomyelitis/chronic fatigue syndrome: moving beyond XMRV , 2013, Fatigue : biomedicine, health & behavior.
[9] Le-Xin Wang,et al. Diagnosis and management of postural orthostatic tachycardia syndrome: A brief review , 2012, Journal of geriatric cardiology : JGC.
[10] Scott B. Dewell,et al. Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes , 2011, The Journal of investigative dermatology.
[11] D. Roth,et al. How big is the Lyme problem? Using novel methods to estimate the true number of Lyme disease cases in British Columbia residents from 1997 to 2008. , 2011, Vector borne and zoonotic diseases.
[12] Avrum Spira,et al. Characterizing the Impact of Smoking and Lung Cancer on the Airway Transcriptome Using RNA-Seq , 2011, Cancer Prevention Research.
[13] T. Fleisher,et al. Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls , 2009, Clinical and Vaccine Immunology.
[14] R. Bratton,et al. Diagnosis and treatment of Lyme disease. , 2008, Mayo Clinic proceedings.
[15] J. Halperin,et al. Erratum: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America (Clinical Infectious Diseases (2006) 43, (1089-1134)) , 2007 .
[16] H Artsob,et al. A critical appraisal of "chronic Lyme disease". , 2007, The New England journal of medicine.
[17] J. Naschitz,et al. Orthostatic hypotension: framework of the syndrome , 2007, Postgraduate Medical Journal.
[18] J. Halperin,et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] B. Carruthers. Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works , 2006, Journal of Clinical Pathology.
[20] Ira Schwartz,et al. Diagnosis of Lyme Borreliosis , 2005, Clinical Microbiology Reviews.
[21] Suzanne D Vernon,et al. Cost Effectiveness and Resource Allocation Open Access the Economic Impact of Chronic Fatigue Syndrome , 2022 .
[22] N. Harris,et al. Evidence-based guidelines for the management of Lyme disease , 2004, Expert review of anti-infective therapy.
[23] D. Papanicolaou,et al. Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population , 2003, Health and quality of life outcomes.
[24] R. Stricker,et al. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. , 2001, Immunology letters.
[25] R. Schondorf,et al. The importance of orthostatic intolerance in the chronic fatigue syndrome. , 1999, The American journal of the medical sciences.
[26] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[27] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[28] D. Burdge,et al. EXPERIENCE AT A REFERRAL CENTER FOR PATIENTS WITH SUSPECTED LYME DISEASE IN AN AREA OF NONENDEMICITY: FIRST 65 PATIENTS , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] N. Larocca,et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.
[30] Daniel J Buysse,et al. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.
[31] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[32] Bhagat S Malhotra,et al. Chronic Fatigue Syndrome: A Review , 2011 .
[33] P. Flor-Henry,et al. Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .
[34] I. Hickie,et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.
[35] D. Karnofsky. The clinical evaluation of chemotherapeutic agents in cancer , 1949 .
[36] L. Radloff. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .